Consun Pharmaceutical Group (FRA:C1P) Cash-to-Debt : 7.01 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Consun Pharmaceutical Group's cash to debt ratio for the quarter that ended in Dec. 2023 was 7.01.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Consun Pharmaceutical Group could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Consun Pharmaceutical Group's Cash-to-Debt or its related term are showing as below:

FRA:C1P' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.74 Med: 5.29 Max: No Debt
Current: 7.01

During the past 12 years, Consun Pharmaceutical Group's highest Cash to Debt Ratio was No Debt. The lowest was 1.74. And the median was 5.29.

FRA:C1P's Cash-to-Debt is ranked better than
73.52% of 1046 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs FRA:C1P: 7.01

Consun Pharmaceutical Group Cash-to-Debt Historical Data

The historical data trend for Consun Pharmaceutical Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Consun Pharmaceutical Group Cash-to-Debt Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

2.50

3.53

3.97

6.61

7.01

Consun Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															3.97	5.12	6.61	5.88	7.01

Competitive Comparison of Consun Pharmaceutical Group's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Consun Pharmaceutical Group's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Cash-to-Debt falls into.

Consun Pharmaceutical Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Consun Pharmaceutical Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	460.183	/	(65.195	+	0.501)
	=	7.00

Consun Pharmaceutical Group's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	460.183	/	(65.195	+	0.501)
	=	7.00

Consun Pharmaceutical Group (FRA:C1P) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Consun Pharmaceutical Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group (FRA:C1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (FRA:C1P) » Definitions » Cash-to-Debt

Traded in Other Exchanges

01681:Hong Kong

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group (FRA:C1P) Headlines

No Headlines